Shares of Bio-Techne Corp. TECH shed 2.18% to $57.35 Tuesday, on what proved to be an all-around mixed trading session for ...

Shares of Bio-Techne Corp. TECH shed 2.04% to $58.73 Friday, on what proved to be an all-around poor trading session for the ...

Shareholders of Bio-Techne would probably like to forget the past six months even happened. The stock has dropped 26.9% and ...

TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.

Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...

MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...

Sequoia Financial Advisors LLC increased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 63.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...

Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform recommendation. Analyst Price Forecast Suggests 39.85% Upside As of March 4 ...

Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.